Regeneron Initial Data on Multiple Myeloma Drug Encouraging

• click to rate

  Posted by Two Blokes May 23, 2025 - Filed in Stock - 8 views
  
  REGN posts strong early data for linvoseltamab combos in relapsed/refractory multiple myeloma, with ORRs up to 90% and high complete response rates.